Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1).
Rombos Y, Tzanetea R, Konstantopoulos K, Simitzis S, Zervas C, Kyriaki P, Kavouklis M, Aessopos A, Sakellaropoulos N, Karagiorga M, Kalotychou V, Loukopoulos D.
Rombos Y, et al. Among authors: konstantopoulos k.
Haematologica. 2000 Feb;85(2):115-7.
Haematologica. 2000.
PMID: 10681716
Clinical Trial.